Dying in the City of the Blues: Sickle Cell Anemia and the Politics of Race and Health
Hastings Center Report 32 (4):46 (2002)
Abstract
This article has no associated abstract. (fix it)My notes
Similar books and articles
Dying in the City of the Blues: Sickle Cell Anemia and the Politics of Race and Health. [REVIEW]Pauline Mazumdar - 2005 - Isis 96:465-466.
Keith Wailoo. Dying in the City of the Blues: Sickle Cell Anemia and the Politics of Race and Health. 352 pp., illus., notes, index. Chapel Hill: University of North Carolina Press, 2001. $34.95 ; $16.95. [REVIEW]Pauline M. H. Mazumdar - 2005 - Isis 96 (3):465-466.
Genetic Marker of Segregation: Sickle Cell Anemia, Thalassemia, and Racial Ideology in American Medical Writing 1920-1950.Keith Wailoo - 1996 - History and Philosophy of the Life Sciences 18 (3):305 - 320.
Thinking Through the Pain.Keith Wailoo - 2016 - Perspectives in Biology and Medicine 59 (2):253-262.
Medicine, Culture, and Sickle Cell Disease.Troy Duster - 2002 - Hastings Center Report 32 (4):46-47.
Prevention of Stroke in Sickle Cell Anemia.Robert J. Adams - 2014 - Journal of Law, Medicine and Ethics 42 (2):135-138.
The use of race in medicine as a proxy for genetic differences.Michael Root - 2003 - Philosophy of Science 70 (5):1173-1183.
Treating Pain in Sickle Cell Disease with Opioids: Clinical Advances, Ethical Pitfalls.Wally R. Smith - 2014 - Journal of Law, Medicine and Ethics 42 (2):139-146.
Case Study: Pain and Sickle Cell Anemia.David Resnik, Marsha Rehm & Ben A. Rich - 2001 - Hastings Center Report 31 (3):29.
The Troubled Dream of Genetic Medicine: Ethnicity and Innovation in Tay Sachs, Cystic Fibrosis and Sickle Cell Disease.Keith Wailoo & Stephen Pemberton - 2007 - Journal of the History of Biology 40 (3):598-600.
Keith Wailoo;, Stephen Pemberton. The Troubled Dream of Genetic Medicine: Ethnicity and Innovation in Tay‐Sachs, Cystic Fibrosis, and Sickle Cell Disease. x + 249 pp., index. Baltimore: Johns Hopkins University Press, 2006. $21.95. [REVIEW]Michel Morange - 2008 - Isis 99 (1):229-230.
Mechanisms and causality in molecular diseases.Shannon E. Keenan & Stanislav Y. Shvartsman - 2017 - History and Philosophy of the Life Sciences 39 (4):35.
Sickle Cell Disease and the “Difficult Patient” Conundrum.Edward J. Bergman & Nicholas J. Diamond - 2013 - American Journal of Bioethics 13 (4):3 - 10.
Analytics
Added to PP
2018-04-09
Downloads
4 (#1,241,029)
6 months
4 (#186,020)
2018-04-09
Downloads
4 (#1,241,029)
6 months
4 (#186,020)
Historical graph of downloads
Sorry, there are not enough data points to plot this chart.
Citations of this work
Sickle Cell Disease and the “Difficult Patient” Conundrum.Edward J. Bergman & Nicholas J. Diamond - 2013 - American Journal of Bioethics 13 (4):3 - 10.
Review of Marybeth Gasman and Louis W. Sullivan, The Morehouse Mystique: Becoming a Doctor at the Nation's Newest African American Medical School 1. [REVIEW]Rana Asali Hogarth - 2012 - American Journal of Bioethics 12 (11):51-52.
Pharmaceutical Meaning-Making Beyond Marketing: Racialized Subjects of Generic Thiazide.Anne Pollock - 2008 - Journal of Law, Medicine and Ethics 36 (3):530-536.
Pharmaceutical Meaning-Making beyond Marketing: Racialized Subjects of Generic Thiazide.Anne Pollock - 2008 - Journal of Law, Medicine and Ethics 36 (3):530-536.
Screening Out Controversy: Human Genetics, Emerging Techniques of Diagnosis, and the Origins of the Social Issues Committee of the American Society of Human Genetics, 1964–1973.M. X. Mitchell - 2017 - Journal of the History of Biology 50 (2):425-456.
